The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lymphoma: results of a randomized UK National Cancer Research Institute trial

导出原文传递

翻译打印收藏纠错

作者： Rule, Simon ^[1] ; Smith, Paul ^[2] ; Johnson, Peter W. M. ^[3] ; Bolam, Simon ^[4] ; Follows, George ^[5] ; Gambell, Joanne ^[6] ; Hillmen, Peter ^[7] ; Jack, Andrew ^[8] ; Johnson, Stephen ^[9] ; Kirkwood, Amy A. ^[10] ; Kruger, Anton ^[11] ; Pocock, Christopher ^[12] ; Seymour, John F. ; Toncheva, Milena ; Walewski, Jan ; Linch, David

作者单位： Royal Cornwall Hosp, Truro, England ^[1] UCL, Inst Canc, London, England ^[2] Derriford Hosp, Plymouth, Devon, England ^[3] Maria Sklodowska Curie Inst & Oncol Ctr, Gliwice, Poland ^[4] Univ Southampton, Southampton, Hants, England ^[5] St James Univ Hosp, Leeds, W Yorkshire, England ^[6] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia ^[7] Canc Reasearch UK, London, England ^[8] Addenbrookes Hosp, Cambridge, England ^[9] Leeds Gen Infirm, HMDS, Leeds, W Yorkshire, England ^[10] Kent & Canterbury Hosp, Canterbury, Kent, England ^[11] Musgrove Pk Hosp, Taunton, Somerset, England ^[12]

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Haematologica

2016年101卷2期

235-240页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lymphoma: results of a randomized UK National Cancer Research Institute trial

Haematologica

相似文献

Haematologica

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lymphoma: results of a randomized UK National Cancer Research Institute trial

Haematologica

相似文献

Haematologica

相关期刊

检索历史清除